{ "docId": "019dd923-5ca1-7489-b639-45501f4b359b", "docSlug": "158df8627a0b9aca", "documentTitle": "Opioid Conflicts Majority Staff Report", "authorId": "McKinsey", "authorName": "U.S. House Committee on Oversight and Reform", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 40, "pageCount": 53, "prevPage": 39, "nextPage": 41, "slideType": "appendix_disclosure", "function": "summarize", "density": "overcrowded", "nDataPoints": 0, "notes": "This appears to be a page from a formal investigative report or legal document.", "elementsJson": [ "paragraph", "bullet_list", "footnote" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/40", "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b", "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json", "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-40", "components": [ { "bbox": null, "kind": "callout", "text": "The Committee's investigation has uncovered evidence that McKinsey's Healthcare Systems and Services practice—a government and policy facing health care practice at McKinsey—sought input from members of its private sector pharmaceutical practice, who served Purdue and other opioid manufacturers.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd951-cdec-74db-b49d-4dece38811ef", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.78, "x": 0.11, "y": 0.2 }, "kind": "list", "text": "Federal agencies, including the Centers for Medicare and Medicaid Services, the Centers for Disease Control and Prevention (CDC), and the Substance Abuse and Mental Health Services Administration; States and state agencies, including Virginia, Missouri, Massachusetts, New Hampshire, Delaware, Vermont, Ohio Medicaid, Ohio Corrections, and Alabama Medicaid; and Local governments, including New York City and elsewhere.", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "7b461a57-d2a4-46b6-8f7d-d289858da769", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.78, "x": 0.11, "y": 0.11 }, "kind": "paragraph", "text": "The extent to which McKinsey's management followed this guidance for its contracts with FDA is unclear. In addition, McKinsey's potential opioid-related conflicts of interest may extend to its work for numerous other federal and state government entities.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5b322b25-3acb-4da6-a2c5-f76d6b2c2e81", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.04, "w": 0.78, "x": 0.11, "y": 0.38 }, "kind": "paragraph", "text": "The McKinsey Organizational Conflicts of Interest Policy states that it may be used \"[w]here appropriate\" as \"guidance when responding to state and local procurements.\"", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "6c9c74b2-b4b5-42d3-8aab-fdddb594a25b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.78, "x": 0.11, "y": 0.59 }, "kind": "paragraph", "text": "The Committee's investigation has uncovered evidence that McKinsey's Healthcare Systems and Services practice—a government and policy facing health care practice at McKinsey—sought input from members of its private sector pharmaceutical practice, who served Purdue and other opioid manufacturers.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "6fcc9b43-ae31-4edd-9808-7ada74fa4d2a", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.07, "w": 0.78, "x": 0.11, "y": 0.49 }, "kind": "paragraph", "text": "Documents obtained by the Committee suggest that McKinsey may have sought to use its influence with government clients to advocate for policy positions or selectively share information with government officials that benefited its private sector clients.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "9f374d99-e941-4226-9608-46705c669c61", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.78, "x": 0.11, "y": 0.82 }, "kind": "source-note", "text": "190 MCK-HCOR-0127852. 191 MCK-HCOR-0352178, Page 1. 192 McKinsey & Company, Healthcare Systems & Services (online at www.mckinsey.com/industries/healthcare-systems-and-services/how-we-help-clients) (accessed Feb. 22, 2022).", "attrs": { "numbered": true }, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "f097d4f3-e1ea-4910-8d4b-f391f22a8aa8", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.78, "x": 0.11, "y": 0.43 }, "kind": "title", "text": "D. McKinsey Consultants Working for Opioid Manufacturers Influenced Policy Documents McKinsey Submitted to Government Clients", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "701ff83d-5f17-4f32-86ec-8d9f1234dbc9", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 53, "from": 29, "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "loops": [ { "to": 53, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033", "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.", "position": 0, "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 24, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "308c22ef-34f3-45b8-b50d-c273c6edeb88", "evidence": "The document presents the concerns of regulatory bodies through examples of McKinsey's actions and lack of disclosure.", "position": 1, "objective": "What are the concerns of regulatory bodies regarding McKinsey's conflicts of interest?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }